Insider Trading History of Jobe James R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Jobe James R since 2013. This trader's CIK number is 1362322. At the time of last reporting, Jobe James R was the Director of National Health Investors Inc. (stock ticker symbol NHI). Also see all insider trading activities at National Health Investors Inc.


Yearly summary of insider trading at National Health Investors Inc (NHI) by Jobe James R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 NHI 0 $0 0 $0 45,000 $2,488,500
2023 NHI 1,000 $51,398 0 $0 0 $0
2020 NHI 0 $0 0 $0 25,000 $1,998,999
2019 NHI 0 $0 900 $74,911 0 $0
2018 NHI 0 $0 0 $0 20,000 $1,286,600
2017 NHI 0 $0 0 $0 20,000 $1,495,600
2016 NHI 0 $0 0 $0 20,000 $1,442,200
2015 NHI 400 $24,813 0 $0 15,000 $919,650
2014 NHI 1,900 $119,076 0 $0 0 $0
2013 NHI 100 $6,385 0 $0 0 $0


Insider trading of National Health Investors Inc (NHI) by Jobe James R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-08-23 NHI Option Ex 45,000 55.30 2,488,500
2023-08-30 NHI Buy 1,000 51.40 51,398
2020-02-07 NHI Option Ex 25,000 79.96 1,998,999
2019-09-24 NHI Sale 900 83.23 74,911
2018-08-07 NHI Option Ex 20,000 64.33 1,286,600
2017-07-03 NHI Option Ex 20,000 74.78 1,495,600
2016-07-01 NHI Option Ex 20,000 72.11 1,442,200
2015-08-25 NHI Buy 100 56.68 5,668
2015-08-13 NHI Buy 100 58.71 5,871
2015-05-14 NHI Buy 200 66.37 13,274
2015-01-08 NHI Option Ex 15,000 61.31 919,650
2014-06-24 NHI Buy 1,000 63.47 63,470
2014-05-13 NHI Buy 900 61.78 55,606
2013-05-31 NHI Buy 100 63.85 6,385

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jobe James R (Director of National Health Investors Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.